Neuro-Oncology Reviews

Volume 22 Number 4
29 February 2020

Home > Publications > Neuro-Oncology Reviews > Volume 22, Year 2020 > Number 4, 29 February

Shen SH, Woroniecka K, Barbour AB, Fecci PE, Sanchez-Perez L, Sampson JH.
CAR T cells and checkpoint inhibition for the treatment of glioblastoma.
Expert Opin Biol Ther. 2020 Feb 17;20(6):579-591→. doi: 10.1080/14712598.2020.1727436→. PMID: 32027536→. Review. ˍ

Alimohammadi E, Bagheri SR, Taheri S, Dayani M, Abdi A.
The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma multiforme: a meta-analysis and systematic review.
Oncol Rev. 2020 Feb 18;14(1):461→. doi: 10.4081/oncol.2020.461→. PMID: 32153727→. Review, Meta-analysis. ˍ

Liu J, Qu C, Han C, Chen MM, An LJ, Zou W.
Potassium channels and their role in glioma: a mini review.
Mol Membr Biol. 2020 Feb 18;35(1):76-85→. doi: 10.1080/09687688.2020.1729428→. PMID: 32067536→. Review. ˍ

Wang SC, Chen SJ, Chen YC.
Potential Therapeutic Approaches Against Brain Diseases Associated with Cytomegalovirus Infections.
Int J Mol Sci. 2020 Feb 18;21(4):E1376→. doi: 10.3390/ijms21041376→. PMID: 32085671→. Review. ˍ

Stegmayr C, Stoffels G, Filß C, Heinzel A, Lohmann P, Willuweit A, Ermert J, Coenen HH, Mottaghy FM, Galldiks N, Langen KJ.
Current trends in the use of O-(2-[¹⁸F]fluoroethyl)-L-tyrosine ([¹⁸F]FET) in neurooncology.
Nucl Med Biol. 2020 Feb 19;92:78-84→. doi: 10.1016/j.nucmedbio.2020.02.006→. PMID: 32113820→. Review. ˍ

Arnold CR, Mangesius J, Skvortsova II, Ganswindt U.
The Role of Cancer Stem Cells in Radiation Resistance.
Front Oncol. 2020 Feb 20;10:164→. doi: 10.3389/fonc.2020.00164→. PMID: 32154167→. Review. ˍ

Grothey A, Blay JY, Pavlakis N, Yoshino T, Bruix J.
Evolving role of regorafenib for the treatment of advanced cancers.
Cancer Treat Rev. 2020 Feb 20;86:101993→. doi: 10.1016/j.ctrv.2020.101993→. PMID: 32199197→. Review. ˍ

Ritchey AK et al, PDQ Pediatric Treatment Editorial Board.
Childhood Brain Stem Glioma Treatment (PDQ®): Patient Version.
PDQ Cancer Inf Summ. 2020 Feb 20→. NCBI Bookshelf ID: NBK65812→. PMID: 26389253→. Review. ˍ

Patterson JD, Wongsurawat T, Rodriguez A.
A Glioblastoma Genomics Primer for Clinicians.
Med Res Arch. 2020 Feb 21;8(2):10.18103/mra.v8i2.2034→. doi: 10.18103/mra.v8i2.2034→. PMID: 32258388→. Review. ˍ

Mazurek M, Litak J, Kamieniak P, Osuchowska I, Maciejewski R, Roliński J, Grajkowska W, Grochowski C.
Micro RNA Molecules as Modulators of Treatment Resistance, Immune Checkpoints Controllers and Sensitive Biomarkers in Glioblastoma Multiforme.
Int J Mol Sci. 2020 Feb 22;21(4):E1507→. doi: 10.3390/ijms21041507→. PMID: 32098401→. Review. ˍ

Kameda-Smith MM.
Pediatric medulloblastoma in the molecular era: what are the surgical implications?
Cancer Metastasis Rev. 2020 Feb 24;39(1):235-243→. doi: 10.1007/s10555-020-09865-y→. PMID: 32095940→. Review. ˍ

Liu X, Ding C, Tan W, Zhang A.
Medulloblastoma: Molecular understanding, treatment evolution, and new developments.
Pharmacol Ther. 2020 Feb 24:107516→. doi: 10.1016/j.pharmthera.2020.107516→. PMID: 32105673→. Review. ˍ

Cheng M, Zhang ZW, Ji XH, Xu Y, Bian E, Zhao B.
Super-enhancers: A new frontier for glioma treatment.
Biochim Biophys Acta Rev Cancer. 2020 Feb 26;1873(2):188353→. doi: 10.1016/j.bbcan.2020.188353→. PMID: 32112817→. Review. ˍ

Masui K, Harachi M, K Cavenee W, S Mischel P, Shibata N.
Codependency of Metabolism and Epigenetics Drives Cancer Progression: A Review.
Acta Histochem Cytochem. 2020 Feb 26;53(1):1-10→. doi: 10.1267/ahc.20002→. PMID: 32201436→. Review. ˍ

Beccaria K, Canney M, Bouchoux G, Desseaux C, Grill J, Heimberger AB, Carpentier A.
Ultrasound-induced blood-brain barrier disruption for the treatment of gliomas and other primary CNS tumors.
Cancer Lett. 2020 Feb 27;479:13-22→. doi: 10.1016/j.canlet.2020.02.013→. PMID: 32112904→. Review. ˍ

D'Angelo L, Armocida D, Sampirisi L, Paglia F, Berra LV, Santoro A.
Role of endoscopic surgical biopsy in diagnoses of intraventricular/periventricular tumors: review of literature including a monocentric case series.
Acta Neurol Belg. 2020 Feb 27;120(3):517-530→. doi: 10.1007/s13760-020-01299-1→. PMID: 32107717→. Review. ˍ

Kelly WJ, Gilbert MR.
Glucocorticoids and immune checkpoint inhibitors in glioblastoma.
J Neurooncol. 2020 Feb 27, 2021;151(1):13-20→. doi: 10.1007/s11060-020-03439-2→. PMID: 32108294→. Review. ˍ

Schreck KC, Patel MP, Wemmer J, Grossman SA, Peters KB.
RAF and MEK inhibitor therapy in adult patients with brain tumors: a case-based overview and practical management of adverse events.
Neurooncol Pract. 2020 Feb 27;7(4):369-375→. doi: 10.1093/nop/npaa006→. PMID: 32765888→. Review. ˍ

Meng Y, Tang C, Yu J, Meng S, Zhang W.
Exposure to lead increases the risk of meningioma and brain cancer: A meta-analysis.
J Trace Elem Med Biol. 2020 Feb 27;60:126474→. doi: 10.1016/j.jtemb.2020.126474→. PMID: 32146339→. Meta-analysis. ˍ

Arafa K, Emara M.
Insights About Circadian Clock and Molecular Pathogenesis in Gliomas.
Front Oncol. 2020 Feb 28;10:199→. doi: 10.3389/fonc.2020.00199→. PMID: 32195174→. Review. ˍ

Beccaria K, Sabbagh A, de Groot J, Canney M, Carpentier A, Heimberger AB.
Blood-brain barrier opening with low intensity pulsed ultrasound for immune modulation and immune therapeutic delivery to CNS tumors.
J Neurooncol. 2020 Feb 28;151(1):65-73→. doi: 10.1007/s11060-020-03425-8→. PMID: 32112296→. Review. ˍ

Yekula A, Gupta M, Coley N, U HS.
Adult H3K27M-mutant diffuse midline glioma with gliomatosis cerebri growth pattern: Case report and review of the literature.
Int J Surg Case Rep. 2020 Feb 28;68:124-128→. doi: 10.1016/j.ijscr.2020.02.046→. PMID: 32145563→. Case report, Review. ˍ

Berger TR, Wong ET.
Tumor treating fields in neuro-oncology: integration of alternating electric fields therapy into promising treatment strategies.
Chin Clin Oncol. 2020 Feb 29, 2021;10(4):36→. doi: 10.21037/cco.2020.02.04→. PMID: 32156119→. Review. ˍ